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A 33-year-old man, who denied chronic renal disease, was
referred to us for evaluation of proteinuria. After a 3-week
upper-respiratory infection, he reported to his physician,
who observed a hemoglobin count of 9.5 g/dl, a serum
albumin level of 2.3 g/dl, and proteinuria of 1.8 g per 24 h.
The referring physician suspected IgA (immunoglobulin A)
nephropathy. At our referral center, the initial physical evaluation
showed a normal blood pressure and a normal physical
examination, with the exception of the patient’s eyes (Figure 1).
The laboratory reported normal electrolytes, an estimated
glomerular filtration rate of 114 ml/min, no abnormal anti-
bodies, normal complement levels, and a transferrin saturation
of 30% with a ferritin level of 822mg/l. The urinary sediment
disclosed dysmorphic erythrocytes consistent with glomerulone-
phritis. The serum lipid values showed a total cholesterol level of
153 mg/dl, a high-density lipoprotein cholesterol (HDL) level
of 11 mg/dl, an LDL (low-density lipoprotein) cholesterol level
of 3 mg/dl, and triglycerides at 544 mg/dl.
What is the clinical diagnosis?
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Figure 1 |A most obvious finding was the corneal
opacity of the patient’s eye.
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The Diagnosis | Lecithin cholesterol acyltransferase
(LCAT) deficiency
The patient reported that one of his brothers also had
abnormal eyes, as did his father (Figure 2a).1 A kidney biopsy
showed focal segmental glomerulosclerosis (Figure 2b).
Electron microscopy detected lipid deposits with both vacuolar
lucent appearance and electron-dense lamellar structures
within the mesangial matrix and glomerular basement
membrane (Figure 2c). The finding of ‘Fish Eyes’ and low
HDL levels, along with renal biopsy findings suggested LCAT
deficiency. LCAT gene sequencing in our patient revealed two
hitherto undescribed mutations in LCAT, namely a deletion on
one allele resulting in a stop codon (193delG in exon 2) and a
point mutation on the other (602T4A, exon 5).2
LCAT, also known as phosphatidylcholine-sterol O-
acyltransferase, is an enzyme that converts free cholesterol
into cholesteryl ester, which is a more hydrophobic form of
cholesterol (Figure 2d).3 This product is then sequestered
into the core of a lipoprotein particle, eventually making the
newly synthesized HDL spherical and forcing the reaction to
become unidirectional as the particles are removed from the
surface. The enzyme is bound to HDL and LDL in the blood
plasma. The disease has two forms, familial LCAT deficiency,
in which there is complete LCAT deficiency, and ‘fish eye’
disease, in which there is a partial deficiency. Both are
autosomal recessive disorders caused by mutations of the
LCAT gene on chromosome 16q22.4
LCAT knockout mice have partly helped our under-
standing of the pathogenesis of this disease.5 Knockout mice
had low-HDL and non-HDL cholesterol levels. Some of these
mice accumulated lipoprotein X, a lamellar particle of
30–70 nm in diameter, with a high phospholipid (66%) and
unesterified cholesterol (22%) content. Proteinuria and renal
lesions were detected only in mice that accumulated
lipoprotein X in their kidneys. Glomeruli of the affected
animals showed glomerulosclerosis with increased amounts
of extracellular matrix in the mesangium and occasional
macrophages, similar to that seen in our patient’s biopsy.
These data suggest an etiological role for lipoprotein X in the
development of glomerulosclerosis, although the exact
mechanism is unknown. In addition, lipoprotein X may
cause pseudohyponatremia, which our patient did not have.6
Eye lesions were not present in the LCAT-deficient mice.
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Figure 2 |Pedigree and renal histology in an LCAT-deficient patient. (a) Shows the family tree. The proband’s children must be
heterozygous; thus far, they have no phenotype. (b) Shows a silver stain revealing focal segmental glomerulosclerosis. (c) Shows an electron
microscopic image of lipid deposits with vacuolar lucent appearance and electron-dense lamellar structures within the mesangial matrix
and glomerular basement membrane. (d) Depicts LCAT function.
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